Chinese trade negotiators suddenly canceled a visit to meet U.S. farmers after they wrapped up trade talks in Washington this week.Marketsread more
Blackstone Executive Vice Chairman Tony James says he's less optimistic now than before that the U.S.-China trade war could be resolved, but even a smaller deal could help...World Economyread more
The Pentagon will deploy U.S. forces to the Middle East on the heels of the attack on Saudi Arabian oil facilities, United States Secretary of Defense Mark Esper announced...Defenseread more
President Trump also said he is "not looking for a partial deal" with Beijing, moving away from his suggestion last week that he would consider an "interim deal."Politicsread more
Progress on trade talks will determine how far market will move above new highs.Trader Talk with Bob Pisaniread more
"Sure, the trade war's taking its toll on business ... it's just not taking its toll where it was supposed to," Jim Cramer says.Mad Money with Jim Cramerread more
Joe Biden called on President Donald Trump Friday to release the transcript of a call with a foreign leader that is the subject of a whistleblower complaint. Biden described...Politicsread more
For investors taking a breather from the chaos in August, buckle up as the market is about go crazy again, Goldman Sachs warned.Marketsread more
Palantir Technologies is targeting a valuation of at least $26 billion in a private fundraising round, the first for the Peter Thiel-backed data analytics startup in four...Wall Streetread more
Michael Pack, a conservative filmmaker linked to Steve Bannon, saw at least $1.6 million in donations from his nonprofit sent into the coffers of his independent production...Politicsread more
The New England Patriots released Antonio Brown just 11 days after signing the wide receiver. The NFL Super Bowl champion team initially had kept him in the face of a rape...Sportsread more
A lawyer for pharma bro Martin Shkreli suggested Friday after a hearing at Brooklyn federal court that there are a number of witnesses who could testify that the accused fraudster is innocent.
"There a number of witness who exculpate Martin. A lot of them do talk to us, some of them don't," Shkreli's lawyer Marc Agnifilo said. "If these witnesses are going to come through I think we're going to have the makings of a very good defense."
Shkreli's lawyers previously suggested that his defense would be based on the claim that he had been relying on the advice of his lawyer and current co-defendant, Evan Greebel, for the conduct which is the basis of the indictment against them both.
When asked what his defense would be other than that claim, he said, "I don't think Martin broke the law. It's the oldest defense in the book."
"I think he's innocent. I think he did not break the law, and I don't think anybody can prove that he did."
Shkreli, 33, is accused by prosecutors of looting the pharma company Retrophin that he was then heading of $11 million to pay off investors he was suspected of previously defrauding in a hedge fund he ran.
Retrophin's board ousted Shkreli in 2014, and later sued him for $65 million in connection with his alleged plundering of the company.
Greebel's lawyer, Reed Brodsky, said during the hearing they were contemplating making a request to sever the trial and have each defendant tried separately. This marked the first time Greebel's lawyers raised the possibility they may request a separate trial.
Shkreli's lawyers had suggested the severance in previous hearings. As of Friday they hadn't yet reached a decision, but Agnifilo did note that, "If we can sever it, I think it's a cleaner trial for both of us so we'll see."
Greebel's lawyers also remarked that the government had not disclosed enough potentially exculpatory material for their client. They acknowledged, however, that they were having a hard time searching through the more than 3 million documents already provided to them by prosecutors.
They suggested that they would argue Greebel was misled by Shkreli, and thus innocent and not a conspirator. "We want evidence that Shkreli lied or deceived Mr. Greebel," Brodsky said during the two-hour hearing.
During the proceeding, a prosecutor brought up the moment Shkreli was arrested on December 17, 2015, and handcuffed to an office railing. At that moment, Shkreli grinned broadly at an FBI agent sitting at the prosecution's table, who then smiled back wryly, seemingly acknowledging the moment.
Shkreli gained notoriety last year after raising the price of a drug used to treat toxoplasmosis by more than 5,500 percent as CEO of Turing Pharmaceuticals, the company that he founded after Retrophin's board ousted him. The price of Daraprim jumped from $13.50 per pill to $750 per pill.
Although the price hike drew widespread outrage, it had nothing to do with the criminal conspiracy and securities fraud charges that were subsequently lodged against him.
After the hearing, Shkreli was asked about the status of an auction in which he was offering people the chance to hit him in the face.
He quickly said "I think we're done, thanks a lot" and began walking away.